(Reuters) -Swedish medical equipment maker Getinge reported first-quarter core earnings slightly below market expectations on Tuesday, dragged by a decline in sales of operating tables and challenges in the Bio-Processing product category.
Its adjusted earnings before interest, taxes and amortisation (EBITA) rose 19% to 1.00 billion Swedish crowns ($105.45 million) in the quarter. Analysts were expecting 1.01 billion crowns on average, a company-provided poll showed.
Commenting on U.S. President Donald Trump’s import duties, the company said the trade war would ultimately affect hospitals and patients the most, as tariffs distort competition and lead to higher costs.
“Getinge is preparing for various scenarios and potential necessary actions, where price adjustments are one of many tools available to counteract negative effects on profitability,” it added.
Getinge makes more than a third of its sales in the United States.
The maker of products for surgery, intensive care and sterilisation reaffirmed its 2025 guidance for organic sales growth of between 2% and 5%.
($1 = 9.4833 Swedish crowns)
(Reporting by Marta Frąckowiak in Gdansk; Editing by Milla Nissi)
Comments